Arkolith/Insider Trading/HQL/Form 4

Weinstein Boaz

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed Apr 22, 2024
Net Buying
Open-Market Buys
$1.6M
Open-Market Sells
$0
Net Open-Market Flow
$1.6M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 19, 2024Buy(P)42K$12.84$545K2.7M
Apr 18, 2024Buy(P)82K$12.80$1.0M2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML